These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38841103)

  • 41. The
    Deming Y; Filipello F; Cignarella F; Cantoni C; Hsu S; Mikesell R; Li Z; Del-Aguila JL; Dube U; Farias FG; Bradley J; Budde J; Ibanez L; Fernandez MV; Blennow K; Zetterberg H; Heslegrave A; Johansson PM; Svensson J; Nellgård B; Lleo A; Alcolea D; Clarimon J; Rami L; Molinuevo JL; Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Ewers M; Harari O; Haass C; Brett TJ; Benitez BA; Karch CM; Piccio L; Cruchaga C
    Sci Transl Med; 2019 Aug; 11(505):. PubMed ID: 31413141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease.
    Gispert JD; Suárez-Calvet M; Monté GC; Tucholka A; Falcon C; Rojas S; Rami L; Sánchez-Valle R; Lladó A; Kleinberger G; Haass C; Molinuevo JL
    Alzheimers Dement; 2016 Dec; 12(12):1259-1272. PubMed ID: 27423963
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genome-wide association study identifies Alzheimer's risk variant in MS4A6A influencing cerebrospinal fluid sTREM2 levels.
    Hou XH; Bi YL; Tan MS; Xu W; Li JQ; Shen XN; Dou KX; Tan CC; Tan L; ; Yu JT
    Neurobiol Aging; 2019 Dec; 84():241.e13-241.e20. PubMed ID: 31204042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.
    Piccio L; Deming Y; Del-Águila JL; Ghezzi L; Holtzman DM; Fagan AM; Fenoglio C; Galimberti D; Borroni B; Cruchaga C
    Acta Neuropathol; 2016 Jun; 131(6):925-33. PubMed ID: 26754641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decoding sTREM2: its impact on Alzheimer's disease - a comprehensive review of mechanisms and implications.
    Lin C; Kong Y; Chen Q; Zeng J; Pan X; Miao J
    Front Aging Neurosci; 2024; 16():1420731. PubMed ID: 38912524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The association between cerebrospinal ferritin and soluble triggering receptor expressed on myeloid cells 2 along Alzheimer's continuum.
    Shi X; Zhong X; Zhou H; Zhou N; Hu Y; Ning Y;
    Front Neurol; 2022; 13():961842. PubMed ID: 36408515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurofilament Light Chain as a Potential Biomarker in Plasma for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and a Meta-Analysis.
    Fan Z; Liu X; Liu J; Chen C; Zhou M
    J Integr Neurosci; 2023 Jun; 22(4):85. PubMed ID: 37519166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Systematic Review and Meta-Analysis of Cerebrospinal Fluid Amyloid and Tau Levels Identifies Mild Cognitive Impairment Patients Progressing to Alzheimer's Disease.
    Ma Y; Brettschneider J; Collingwood JF
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer's disease.
    Park SH; Lee EH; Kim HJ; Jo S; Lee S; Seo SW; Park HH; Koh SH; Lee JH
    Sci Rep; 2021 Jun; 11(1):13050. PubMed ID: 34158530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebrospinal Fluid sTREM2 Has Paradoxical Association with Brain Structural Damage Rate in Early- and Late-Stage Alzheimer's Disease.
    Leng F; Zhan Z; Sun Y; Liu F; Edison P; Sun Y; Wang Z;
    J Alzheimers Dis; 2022; 88(1):117-126. PubMed ID: 35491791
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic changes of CSF sTREM2 in preclinical Alzheimer's disease: the CABLE study.
    Ma LZ; Tan L; Bi YL; Shen XN; Xu W; Ma YH; Li HQ; Dong Q; Yu JT
    Mol Neurodegener; 2020 Apr; 15(1):25. PubMed ID: 32276587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Mild Cognitive Impairment: A Meta-Analysis of Randomized Controlled Trials.
    Zhang X; Lan X; Chen C; Ren H; Guo Y
    Front Hum Neurosci; 2021; 15():723715. PubMed ID: 34764859
    [No Abstract]   [Full Text] [Related]  

  • 54. Association between lipocalin-2 and mild cognitive impairment or dementia: A systematic review and meta-analysis of population-based evidence.
    Li X; Wang X; Guo L; Wu K; Wang L; Rao L; Liu X; Kang C; Jiang B; Li Q; Li H; He F; Lu C
    Ageing Res Rev; 2023 Aug; 89():101984. PubMed ID: 37330019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau.
    Henjum K; Quist-Paulsen E; Zetterberg H; Blennow K; Nilsson LNG; Watne LO
    J Neuroinflammation; 2018 Nov; 15(1):304. PubMed ID: 30390679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease.
    Bekris LM; Khrestian M; Dyne E; Shao Y; Pillai JA; Rao SM; Bemiller SM; Lamb B; Fernandez HH; Leverenz JB
    J Neuroimmunol; 2018 Jun; 319():19-27. PubMed ID: 29685286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer's disease.
    Casati M; Ferri E; Gussago C; Mazzola P; Abbate C; Bellelli G; Mari D; Cesari M; Arosio B
    Eur J Neurol; 2018 Jun; 25(6):805-810. PubMed ID: 29377401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum sTREM2: A Potential Biomarker for Mild Cognitive Impairment in Patients With Obstructive Sleep Apnea.
    Jiahuan X; Ying Z; Hongyu J; Zhijing W; Shibo G; Chengyue D; Liangyu F; Fan L; Wei W
    Front Aging Neurosci; 2022; 14():843828. PubMed ID: 35615588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus.
    Yang F; Yang L; Fang X; Deng Y; Mao R; Yan A; Wei W
    J Alzheimers Dis; 2023; 93(4):1341-1354. PubMed ID: 37182875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TREM2 ectodomain and its soluble form in Alzheimer's disease.
    Yang J; Fu Z; Zhang X; Xiong M; Meng L; Zhang Z
    J Neuroinflammation; 2020 Jul; 17(1):204. PubMed ID: 32635934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.